Indication
Plasmodium vivax malaria
Plasmodium vivax malaria is a mosquito-borne parasitic infection caused by the protozoan *Plasmodium vivax*, primarily targeting the hematologic and reticuloendothelial systems. Read more about Plasmodium vivax malaria
63 drugs 50 manufacturers
Drugs that treat it
Common Plasmodium vivax malaria therapies.
HYDROXYCHLOROQUINE SULFATE
MEFLOQUINE HCL
HYDROXYCHLOROQUINE (hydroxychloroquine sulfate)
MEFLOQUINE HCL
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
HYDROXYCHLOROQUINE SULFATE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPlasmodium vivax malaria is a mosquito-borne parasitic infection caused by the protozoan *Plasmodium vivax*, primarily targeting the hematologic and reticuloendothelial systems.
The parasite selectively invades young erythrocytes (reticulocytes) via the Duffy antigen receptor, producing clinical manifestations characterized by paroxysmal fevers, chills, rigors, headache, fatigue, splenomegaly, and anemia.
A defining pathophysiological hallmark is the organism's capacity to form dormant hepatic stages known as hypnozoites, which can reactivate weeks to years later to trigger recurrent clinical relapses.
Although historically described as benign, repeated or severe infections can lead to serious complications such as profound anemia, thrombocytopenia, acute lung injury, and splenic rupture.
- cdc.gov
Plasmodium vivax malaria is a mosquito-borne parasitic infection caused by the protozoan *Plasmodium vivax*, primarily targeting the hematologic and reticuloendothelial systems The parasite selectively invades young erythrocytes (reticulocytes) via the Duffy antigen receptor, producing clinical manifestations characterized by paroxysmal fevers, chills, rigors, headache, fatigue, splenomegaly, and anemia Although historically described as benign, repeated or severe infections can lead to serious ...
- malariaworld.org
Plasmodium vivax malaria is a mosquito-borne parasitic infection caused by the protozoan *Plasmodium vivax*, primarily targeting the hematologic and reticuloendothelial systems
- nih.gov
The parasite selectively invades young erythrocytes (reticulocytes) via the Duffy antigen receptor, producing clinical manifestations characterized by paroxysmal fevers, chills, rigors, headache, fatigue, splenomegaly, and anemia A defining pathophysiological hallmark is the organism's capacity to form dormant hepatic stages known as hypnozoites, which can reactivate weeks to years later to trigger recurrent clinical relapses Although historically described as benign, repeated or severe infectio...
- flinders.edu.au
The parasite selectively invades young erythrocytes (reticulocytes) via the Duffy antigen receptor, producing clinical manifestations characterized by paroxysmal fevers, chills, rigors, headache, fatigue, splenomegaly, and anemia Although historically described as benign, repeated or severe infections can lead to serious complications such as profound anemia, thrombocytopenia, acute lung injury, and splenic rupture
- nih.gov
A defining pathophysiological hallmark is the organism's capacity to form dormant hepatic stages known as hypnozoites, which can reactivate weeks to years later to trigger recurrent clinical relapses
- cdc.gov
A defining pathophysiological hallmark is the organism's capacity to form dormant hepatic stages known as hypnozoites, which can reactivate weeks to years later to trigger recurrent clinical relapses
- nih.gov
Although historically described as benign, repeated or severe infections can lead to serious complications such as profound anemia, thrombocytopenia, acute lung injury, and splenic rupture
Personalize your experience
Follow Plasmodium vivax malaria and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.